Kwak et al., 1991 - Google Patents

Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy

Kwak et al., 1991

View HTML

Document ID: 2979356015810272947
Author: Kwak L; Campbell M; Zelenetz A; Levy R
Publication year: 1991

External Links

Cited by

Snippet

Persistence of the underlying malignancy remains the major obstacle limiting the success of high-dose chemoradiotherapy with autologous bone marrow transplantation (BMT) for non- Hodgkin's lymphomas. We used the 38C13 murine B-cell lymphoma model to explore the …

Continue reading at www.sciencedirect.com (HTML) (other versions)

230000036039 immunity 0 title abstract description 29

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses

Similar Documents

Publication	Publication Date	Title
Kwak et al.	1992	Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors
Gutstein et al.	1986	Induction of immune tolerance by administration of monoclonal antibody to L3T4.
US4443427A (en)	1984-04-17	Monoclonal antibody
Raychaudhuri et al.	1987	Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
Pierce et al.	1976	Allogeneic carrier-specific enhancement of hapten-specific secondary B-cell responses.
JP2735947B2 (en)	1998-04-02	Idiotype vaccination against B-cell lymphoma
JP2000154153A (en)	2000-06-06	Multistage cascade type vaccine for additional immunity
DK162056B (en)	1991-09-09	Anti-tumour, anti-idiotype antibody for inducing an immunological response
Dunn et al.	1987	Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.
Kwak et al.	1990	Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin
JPH07508174A (en)	1995-09-14	Anti-receptor agent for vitamin B12/transcobalamin 2 receptor
Bazin et al.	1990	Rat hybridomas and rat monoclonal antibodies
Kwak et al.	1991	Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy
Flood et al.	1980	Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
Hurvitz et al.	2005	Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin’s lymphomas: a focus on FavId™
Cosenza et al.	1977	Idiotypes and anti-idiotypes as probes in analysis of immunoregulation
Eig et al.	1977	Complete inhibition of the expression of an idiotype by a mechanism of B-cell dominance.
WO1988000472A1 (en)	1988-01-28	Immunogens and improved methods of making immunogens
Mond et al.	1972	SURFACE ANTIGENS OF IMMUNOCOMPETENT CELLS: III. IN VITRO STUDIES OF THE ROLE OF B AND T CELLS IN IMMUNOLOGICAL MEMORY
Bridges et al.	1987	Selective in vivo antitumor effects of monoclonal anti-IA antibody on B cell lymphoma.
JPS63290826A (en)	1988-11-28	Method of stimulating immune response against specific antigen
JP2639422B2 (en)	1997-08-13	Monoclonal antibodies against Pseudomonas aeruginosa flagella
JPH04501061A (en)	1992-02-27	Induction of antitumor responses by anti-idiotypic antibodies
Kwak et al.	2011	Transfer of specific immunity to B-cell lymphoma with syngeneic bone
Lee et al.	1986	Idiotypic interactions in immune responses to tumor-associated antigens